66

Wai Chun Bio Technology LtdHKG 660 Stock Report

Last reporting period 31 Dec, 2022

Updated 12 Nov, 2024

Last price

Market cap $B

0.021

Micro

Exchange

XHKG - Hong Kong Exchange

660.HK Stock Analysis

66

Uncovered

Wai Chun Bio Technology Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-28/100

Low score

Market cap $B

0.021

Dividend yield

Shares outstanding

1 680.76 B

Wai Chun Bio-Technology Ltd. operates as an investment holding company. The company employs 156 full-time employees Together with its subsidiaries, the Company operates its business through two segments. The Modified Starch and Other Biochemical Products segment is involved in the manufacture and sale of modified starch and other biochemical products. The General Trading segment is involved in the trading of electronic parts, components and electrical appliances.

View Section: Eyestock Rating